These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33852473)

  • 21. Safety and Efficacy of Vitamin K Antagonists vs. Novel Oral Anticoagulants in Patients With Left Ventricular Thrombus: A Meta-Analysis.
    Xuan H; Chen YM; Dai YL; Zhou J; Jiang YF; Zhou YF
    Front Cardiovasc Med; 2021; 8():636491. PubMed ID: 33996936
    [No Abstract]   [Full Text] [Related]  

  • 22. Meta-Analysis Comparing Direct Oral Anticoagulants to Vitamin K Antagonists for The Management of Left Ventricular Thrombus.
    Abdelaziz HK; Megaly M; Debski M; Abdelrahman A; Abdelaziz S; Kamal D; Patel B; More R; Choudhury T
    Expert Rev Cardiovasc Ther; 2021 May; 19(5):427-432. PubMed ID: 33830867
    [No Abstract]   [Full Text] [Related]  

  • 23. Trial sequential analysis of efficacy and safety of direct oral anticoagulants and vitamin K antagonists against left ventricular thrombus.
    Kitano T; Nabeshima Y; Kataoka M; Takeuchi M
    Sci Rep; 2023 Aug; 13(1):13203. PubMed ID: 37580355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: A Retrospective, Multicenter Study and Meta-Analysis of Existing Data.
    Cochran JM; Jia X; Kaczmarek J; Staggers KA; Rifai MA; Hamzeh IR; Birnbaum Y
    J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):173-178. PubMed ID: 33078629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of direct oral anticoagulants versus vitamin K antagonists or warfarin in patients with left ventricular thrombus outcomes: A systematic review and meta-analysis.
    da Silva Ferreira H; Lima Lopes J; Augusto J; Simões J; Roque D; Faria D; Ferreira J; Fialho I; Beringuilho M; Morais H; Ferreira AR; Morais J; Morais C
    Rev Port Cardiol; 2023 Jan; 42(1):63-70. PubMed ID: 36370988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Gupta S; Um KJ; Pandey A; McIntyre WF; Ivanova M; Allahverdi Y; Agahi P; Pandya F; Lopez A; Sachdeva A; Whitlock RP; Belley-Cote EP
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):339-352. PubMed ID: 31011880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis.
    Hu T; Li YH; Han WQ; Maduray K; Chen TS; Hao L; Zhong JQ
    Am J Cardiovasc Drugs; 2023 Nov; 23(6):683-694. PubMed ID: 37639201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis.
    Dong S; Zhang Y; Li Y; Li Y; Miao Y; Zhao R; Zhai S
    Ann Pharmacother; 2021 Apr; 55(4):430-439. PubMed ID: 32938202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis.
    Wu X; Cao S; Yu B; He T
    Blood Coagul Fibrinolysis; 2022 Oct; 33(7):389-401. PubMed ID: 35867933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists.
    Daher J; Da Costa A; Hilaire C; Ferreira T; Pierrard R; Guichard JB; Romeyer C; Isaaz K
    Clin Drug Investig; 2020 Apr; 40(4):343-353. PubMed ID: 32144651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: Systematic Review of Current Literature.
    Kajy M; Shokr M; Ramappa P
    Am J Ther; 2020; 27(6):e584-e590. PubMed ID: 30730331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Oral Anticoagulants Versus Warfarin in Left Ventricular Thrombus: A Systematic Review and Meta-Analysis.
    Salah HM; Goel A; Saluja P; Voruganti D; Al'Aref SJ; Paydak H; Devabhaktuni SR
    Am J Ther; 2021 Aug; ():. PubMed ID: 34387565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct oral anticoagulants to treat left ventricular thrombus-A systematic review and meta-analysis: ELECTRAM investigators.
    Shah S; Shah K; Turagam MK; Sharma A; Natale A; Lakkireddy D; Garg J
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1764-1771. PubMed ID: 33772939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Left Ventricular Thrombus With Direct Oral Anticoagulants: A Retrospective Observational Study.
    Guddeti RR; Anwar M; Walters RW; Apala D; Pajjuru V; Kousa O; Gujjula NR; Alla VM
    Am J Med; 2020 Dec; 133(12):1488-1491. PubMed ID: 32598904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the safety and efficacy of direct oral anticoagulants compared with vitamin-k antagonists in the treatment of left ventricular thrombosis. A systematic review and meta-analysis.
    Mehrpooya M; Barakzehi MR; Nikoobakhsh M
    Heart Lung; 2024; 67():121-136. PubMed ID: 38754272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evidence-based evaluation of left ventricular thrombus treatment, outcomes, and resolution: a systematic review, pooled analysis and meta-analysis.
    Kwok CS; Bennett S; Borovac JA; Will M; Schwarz K; Lip GYH
    Coron Artery Dis; 2023 Jun; 34(4):260-273. PubMed ID: 36951736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
    Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta-analysis.
    Galliazzo S; Pelitti V; Campiotti L; Poli D; Squizzato A
    Intern Emerg Med; 2023 Mar; 18(2):535-547. PubMed ID: 36746889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve.
    Cao Y; Zheng Y; Li S; Liu F; Xue Z; Yin K; Luo J
    Front Cardiovasc Med; 2022; 9():899906. PubMed ID: 35783817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant Benefit of Uninterrupted DOACs Versus VKA During Catheter Ablation of Atrial Fibrillation.
    Romero J; Cerrud-Rodriguez RC; Alviz I; Diaz JC; Rodriguez D; Arshad S; Cerna L; Taveras J; Grupposo V; Natale A; Garcia M; Di Biase L
    JACC Clin Electrophysiol; 2019 Dec; 5(12):1396-1405. PubMed ID: 31857038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.